{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:38:56Z","timestamp":1780083536499,"version":"3.54.0"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1001\/jamaneurol.2019.0834","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T15:32:23Z","timestamp":1555947143000},"page":"818","source":"Crossref","is-referenced-by-count":27,"title":["Association of Cortical \u03b2-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease"],"prefix":"10.1001","volume":"76","author":[{"given":"Lei","family":"Yu","sequence":"first","affiliation":[{"name":"Rush Alzheimer\u2019s Disease Center, Rush University Medical Center, Chicago, Illinois"},{"name":"Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladislav A.","family":"Petyuk","sequence":"additional","affiliation":[{"name":"Pacific Northwest National Laboratory, Richland, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Tasaki","sequence":"additional","affiliation":[{"name":"Rush Alzheimer\u2019s Disease Center, Rush University Medical Center, Chicago, Illinois"},{"name":"Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Boyle","sequence":"additional","affiliation":[{"name":"Rush Alzheimer\u2019s Disease Center, Rush University Medical Center, Chicago, Illinois"},{"name":"Department of Behavioral Sciences, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Gaiteri","sequence":"additional","affiliation":[{"name":"Rush Alzheimer\u2019s Disease Center, Rush University Medical Center, Chicago, Illinois"},{"name":"Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Schneider","sequence":"additional","affiliation":[{"name":"Rush Alzheimer\u2019s Disease Center, Rush University Medical Center, Chicago, Illinois"},{"name":"Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois"},{"name":"Department of Pathology, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip L.","family":"De Jager","sequence":"additional","affiliation":[{"name":"Center for Translational and Computational Neuroimmunology, Columbia University Medical Center, New York, New York"},{"name":"Cell Circuits Program, Broad Institute, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Bennett","sequence":"additional","affiliation":[{"name":"Rush Alzheimer\u2019s Disease Center, Rush University Medical Center, Chicago, Illinois"},{"name":"Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"noi190020r1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease.","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"issue":"20","key":"noi190020r2","doi-asserted-by":"publisher","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","article-title":"Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.","volume":"90","author":"Schmechel","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"noi190020r3","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1093\/brain\/awy103","article-title":"Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE e4 genotype.","volume":"141","author":"Mishra","year":"2018","journal-title":"Brain"},{"issue":"16","key":"noi190020r4","doi-asserted-by":"publisher","first-page":"6820","DOI":"10.1073\/pnas.0900345106","article-title":"Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer\u2019s disease.","volume":"106","author":"Reiman","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"noi190020r5","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease.","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat Genet"},{"issue":"9","key":"noi190020r6","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1001\/jamaneurol.2013.2815","article-title":"Genetic susceptibility for Alzheimer disease neuritic plaque pathology.","volume":"70","author":"Shulman","year":"2013","journal-title":"JAMA Neurol"},{"issue":"9","key":"noi190020r7","doi-asserted-by":"publisher","first-page":"e1004606","DOI":"10.1371\/journal.pgen.1004606","article-title":"Genome-wide association meta-analysis of neuropathologic features of Alzheimer\u2019s disease and related dementias.","volume":"10","author":"Beecham","year":"2014","journal-title":"PLoS Genet"},{"issue":"338","key":"noi190020r8","doi-asserted-by":"publisher","first-page":"338ra66","DOI":"10.1126\/scitranslmed.aaf2362","article-title":"Tau and A\u00df imaging, CSF measures, and cognition in Alzheimer\u2019s disease.","volume":"8","author":"Brier","year":"2016","journal-title":"Sci Transl Med"},{"issue":"1","key":"noi190020r9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nm.4443","article-title":"Amyloid-\u00df plaques enhance Alzheimer\u2019s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation.","volume":"24","author":"He","year":"2018","journal-title":"Nat Med"},{"issue":"3","key":"noi190020r10","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1001\/archneur.61.3.378","article-title":"Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function.","volume":"61","author":"Bennett","year":"2004","journal-title":"Arch Neurol"},{"issue":"9","key":"noi190020r11","doi-asserted-by":"publisher","first-page":"e859","DOI":"10.1212\/WNL.0000000000006075","article-title":"Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease.","volume":"91","author":"Aschenbrenner","year":"2018","journal-title":"Neurology"},{"issue":"4","key":"noi190020r12","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3233\/JAD-160365","article-title":"Neuritic and diffuse plaque associations with memory in non-cognitively impaired elderly.","volume":"53","author":"Malek-Ahmadi","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"noi190020r13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fnagi.2013.00050","article-title":"Relation of neuropathology with cognitive decline among older persons without dementia.","volume":"5","author":"Boyle","year":"2013","journal-title":"Front Aging Neurosci"},{"issue":"16","key":"noi190020r14","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1212\/WNL.0b013e3182661f74","article-title":"Amyloid-\u00df assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study.","volume":"79","author":"Doraiswamy","year":"2012","journal-title":"Neurology"},{"issue":"10","key":"noi190020r15","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1212\/WNL.0b013e3181d3e3e9","article-title":"Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB.","volume":"74","author":"Resnick","year":"2010","journal-title":"Neurology"},{"issue":"pt 5","key":"noi190020r16","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/brain\/awn320","article-title":"Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects.","volume":"132","author":"Mormino","year":"2009","journal-title":"Brain"},{"issue":"6","key":"noi190020r17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/alzrt226","article-title":"Amyloid \u00df-protein oligomers and Alzheimer\u2019s disease.","volume":"5","author":"Hayden","year":"2013","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"noi190020r18","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years.","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"issue":"5618","key":"noi190020r19","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"issue":"s1","key":"noi190020r20","doi-asserted-by":"publisher","first-page":"S567","DOI":"10.3233\/JAD-179941","article-title":"The amyloid-\u00df oligomer hypothesis: beginning of the third decade.","volume":"64","author":"Cline","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"noi190020r21","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer\u2019s disease.","volume":"155","author":"Lue","year":"1999","journal-title":"Am J Pathol"},{"issue":"6","key":"noi190020r22","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/(ISSN)1531-8249","article-title":"Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease.","volume":"46","author":"McLean","year":"1999","journal-title":"Ann Neurol"},{"issue":"pt 5","key":"noi190020r23","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/brain\/awq065","article-title":"The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia.","volume":"133","author":"Mc Donald","year":"2010","journal-title":"Brain"},{"issue":"699","key":"noi190020r24","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3389\/fnins.2018.00699","article-title":"The molecular and neuropathological consequences of genetic risk for Alzheimer\u2019s dementia.","volume":"12","author":"Tasaki","year":"2018","journal-title":"Front Neurosci"},{"issue":"s1","key":"noi190020r25","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.3233\/JAD-179939","article-title":"Religious Orders Study and Rush Memory and Aging Project.","volume":"64","author":"Bennett","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"noi190020r26","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1212\/01.WNL.0000152982.47274.9E","article-title":"Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.","volume":"64","author":"Bennett","year":"2005","journal-title":"Neurology"},{"issue":"12","key":"noi190020r27","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1212\/WNL.0b013e3181d64786","article-title":"Cognitive decline in incident Alzheimer disease in a community population.","volume":"74","author":"Wilson","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"noi190020r28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/ana.25266","article-title":"Targeted brain proteomics uncover multiple pathways to Alzheimer\u2019s dementia.","volume":"84","author":"Yu","year":"2018","journal-title":"Ann Neurol"},{"issue":"2","key":"noi190020r29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ymeth.2009.07.009","article-title":"Mapping protein abundance patterns in the brain using voxelation combined with liquid chromatography and mass spectrometry.","volume":"50","author":"Petyuk","year":"2010","journal-title":"Methods"},{"issue":"6","key":"noi190020r30","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1021\/pr3001546","article-title":"Label-free quantitative LC-MS proteomics of Alzheimer\u2019s disease and normally aged human brains.","volume":"11","author":"Andreev","year":"2012","journal-title":"J Proteome Res"},{"issue":"7","key":"noi190020r31","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","article-title":"Skyline: an open source document editor for creating and analyzing targeted proteomics experiments.","volume":"26","author":"MacLean","year":"2010","journal-title":"Bioinformatics"},{"issue":"5054","key":"noi190020r32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis.","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"issue":"5580","key":"noi190020r33","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics.","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"issue":"5","key":"noi190020r34","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/jnc.2007.101.issue-5","article-title":"A beta oligomers\u2014a decade of discovery.","volume":"101","author":"Walsh","year":"2007","journal-title":"J Neurochem"},{"issue":"pt 5","key":"noi190020r35","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/brain\/awt062","article-title":"Brain amyloid-\u00df oligomers in ageing and Alzheimer\u2019s disease.","volume":"136","author":"Lesn\u00e9","year":"2013","journal-title":"Brain"},{"issue":"2","key":"noi190020r36","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1006\/exnr.1999.7085","article-title":"The levels of soluble versus insoluble brain Abeta distinguish Alzheimer\u2019s disease from normal and pathologic aging.","volume":"158","author":"Wang","year":"1999","journal-title":"Exp Neurol"},{"key":"noi190020r37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neurobiolaging.2015.09.011","article-title":"Association of APOE with tau-tangle pathology with and without \u00df-amyloid.","volume":"37","author":"Farfel","year":"2016","journal-title":"Neurobiol Aging"},{"issue":"9","key":"noi190020r38","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.neurobiolaging.2007.02.029","article-title":"Alzheimer\u2019s disease-type neuronal tau hyperphosphorylation induced by A \u00df oligomers.","volume":"29","author":"De Felice","year":"2008","journal-title":"Neurobiol Aging"},{"issue":"14","key":"noi190020r39","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1073\/pnas.1017033108","article-title":"Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration.","volume":"108","author":"Jin","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"48","key":"noi190020r40","doi-asserted-by":"publisher","first-page":"17345","DOI":"10.1523\/JNEUROSCI.0172-12.2012","article-title":"Soluble A\u00df promotes wild-type tau pathology in vivo.","volume":"32","author":"Chabrier","year":"2012","journal-title":"J Neurosci"},{"key":"noi190020r41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fncel.2015.00191","article-title":"Soluble amyloid-\u00df oligomers as synaptotoxins leading to cognitive impairment in Alzheimer\u2019s disease.","volume":"9","author":"Ferreira","year":"2015","journal-title":"Front Cell Neurosci"},{"issue":"8","key":"noi190020r42","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory.","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat Med"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamaneurology\/article-pdf\/76\/7\/818\/17684674\/jamaneurology_yu_2019_oi_190020.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T15:00:48Z","timestamp":1562598048000},"score":1,"resource":{"primary":{"URL":"http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/jamaneurol.2019.0834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2019.0834","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7,1]]}}}